Label Changes for:

Victozo (Liraglutide [rDNA orgin]) Injection

April 2013

Changes have been made to the WARNINGS and PRECAUTIONS sections of the safety label.

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – April 2013

 

WARNINGS AND PRECAUTIONS

Pancreatitis
  • Based on spontaneous postmarketing reports, acute pancreatitis, including fatal and non-fatal hemorrhagic or necrotizing pancreatitis, has been observed in patients treated with Victoza.

 

Hide
(web1)